miRs-138 and -424 control palmitoylation-dependent CD95-mediated cell death by targeting acyl protein thioesterases 1 and 2 in CLL.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Blood

• Publication date

  2014-12-06

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/blood-2014-07-586511PMID 25670628PMCID PMC4654424
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• miR‐138 inhibits proliferation by targeting 3‐phosphoinositide‐dependent protein kinase‐1 in non‐small cell lung cancer cells

  2015cited by this paper
• The autodepalmitoylating activity of APT maintains the spatial organization of palmitoylated membrane proteins.

  2014cited by this paper
• Mahogunin-mediated α-tubulin ubiquitination via noncanonical K6 linkage regulates microtubule stability and mitotic spindle orientation

  2014cited by this paper
• Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia

  2014cited by this paper
• A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia

  2013cited by this paper
• Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer

  2013cited by this paper
• Small-molecule activation of the TRAIL receptor DR5 in human cancer cells.

  2013cited by this paper
• Novel Tyrosine Kinase Inhibitors Trigger Drug Sensitivity of Primary CLL Cells by Controlling Glucosylation of Ceramides

  2012cited by this paper
• Distinct Acyl Protein Transferases and Thioesterases Control Surface Expression of Calcium-activated Potassium Channels

  2012cited by this paper
• CD95 Is Part of a Let-7/p53/miR-34 Regulatory Network

  2012cited by this paper
• Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia.

  2012influential reference
• B-cell receptor triggers drug sensitivity of primary CLL cells by controlling glucosylation of ceramides.

  2012cited by this paper
• The down-regulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state.

  2012cited by this paper
• In non‐follicular lymphoproliferative disorders, IGH/BCL2‐fusion is not restricted to chronic lymphocytic leukaemia

  2012cited by this paper
• easyFRAP: an interactive, easy-to-use tool for qualitative and quantitative analysis of FRAP data

  2012cited by this paper
• High Cell Surface Death Receptor Expression Determines Type I Versus Type II Signaling*

  2011cited by this paper
• S-nitrosylation of the death receptor fas promotes fas ligand-mediated apoptosis in cancer cells.

  2011cited by this paper
• Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia

  2011cited by this paper
• Novel X‐linked inhibitor of apoptosis inhibiting compound as sensitizer for TRAIL‐mediated apoptosis in chronic lymphocytic leukaemia with poor prognosis

  2011cited by this paper
• miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia.

  2011cited by this paper
• Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia

  2011cited by this paper
• Global profiling of dynamic protein palmitoylation

  2011cited by this paper
• FKBP12 binds to acylated H-ras and promotes depalmitoylation.

  2011cited by this paper
• CD95 promotes tumour growth

  2011cited by this paper
• Sustained NF‐kappaB activity in chronic lymphocytic leukemia is independent of genetic and epigenetic alterations in the TNFAIP3 (A20) locus

  2011cited by this paper
• Identification of acyl protein thioesterases 1 and 2 as the cellular targets of the Ras-signaling modulators palmostatin B and M.

  2011influential reference
• CD95/Fas promotes tumour growth

  2010cited by this paper
• miRNA-Mediated Functional Changes through Co-Regulating Function Related Genes

  2010cited by this paper
• Acyl-Protein Thioesterase 2 Catalizes the Deacylation of Peripheral Membrane-Associated GAP-43

  2010cited by this paper
• The palmitoylation machinery is a spatially organizing system for peripheral membrane proteins.

  2010cited by this paper
• MicroRNAs as regulators of death receptors signaling

  2010cited by this paper
• Common variants at 2q37.3, 8q24.21, 15q21.3, and 16q24.1 influence chronic lymphocytic leukemia risk

  2010cited by this paper
• The DLEU2/miR-15a/16-1 cluster controls B cell proliferation and its deletion leads to chronic lymphocytic leukemia.

  2010cited by this paper
• Small-molecule inhibition of APT1 affects Ras localization and signaling.

  2010cited by this paper
• MicroRNAs: Target Recognition and Regulatory Functions

  2009cited by this paper
• Large-scale profiling of protein palmitoylation in mammalian cells

  2009cited by this paper
• Proteome Scale Characterization of Human S-Acylated Proteins in Lipid Raft-enriched and Non-raft Membranes*

  2009cited by this paper
• miRNA deregulation by epigenetic silencing disrupts suppression of the oncogene PLAG1 in chronic lymphocytic leukemia.

  2009influential reference
• Redox amplification of apoptosis by caspase-dependent cleavage of glutaredoxin 1 and S-glutathionylation of Fas

  2009cited by this paper
• Palmitoylation of membrane proteins (Review)

  2009cited by this paper
• A functional screen implicates microRNA-138-dependent regulation of the depalmitoylation enzyme APT1 in dendritic spine morphogenesis

  2009cited by this paper
• A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia

  2008cited by this paper
• Targeting lipid metabolism by the lipoprotein lipase inhibitor orlistat results in apoptosis of B-cell chronic lymphocytic leukemia cells

  2008cited by this paper
• Palmitoylation of CD95 facilitates formation of SDS‐stable receptor aggregates that initiate apoptosis signaling

  2007cited by this paper
• Palmitoylated proteins: purification and identification

  2007cited by this paper
• Palmitoylation is required for efficient Fas cell death signaling

  2007cited by this paper
• Chemical probes for the rapid detection of Fatty-acylated proteins in Mammalian cells.

  2007cited by this paper
• Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181.

  2006cited by this paper
• Thematic review series: Lipid Posttranslational Modifications. Protein palmitoylation by a family of DHHC protein S-acyltransferases Published, JLR Papers in Press, April 1, 2006.

  2006cited by this paper
• Induction of CD95 upregulation does not render chronic lymphocytic leukemia B-cells susceptible to CD95-mediated apoptosis.

  2005cited by this paper
• Fas-ligand (CD178) and TRAIL synergistically induce apoptosis of CD40-activated chronic lymphocytic leukemia B cells.

  2005cited by this paper
• UvA-DARE ( Digital Academic Repository ) Inhibitors of XIAP sensitize CD 40-activated chronic lymphocytic leukemia cells to CD 95-mediated apoptosis

  2005cited by this paper
• Inhibitors of XIAP sensitize CD40-activated chronic lymphocytic leukemia cells to CD95-mediated apoptosis.

  2005cited by this paper
• Resistance to CD95-mediated apoptosis of CD40-activated chronic lymphocytic leukemia B cells is not related to lack of DISC molecules expression.

  2004cited by this paper
• Fas engagement induces neurite growth through ERK activation and p35 upregulation

  2003cited by this paper
• Micro RNAs are complementary to 3′ UTR sequence motifs that mediate negative post-transcriptional regulation

  2002cited by this paper
• CD95's deadly mission in the immune system

  2000cited by this paper
• Depalmitoylation of Endothelial Nitric-oxide Synthase by Acyl-protein Thioesterase 1 Is Potentiated by Ca2+-Calmodulin*

  1999cited by this paper
• Somatic Fas mutations in non-Hodgkin's lymphoma: association with extranodal disease and autoimmunity.

  1998cited by this paper
• Differential expression of BCL-2 oncoprotein and Fas antigen on normal peripheral blood and leukemic bone marrow cells. A flow cytometric analysis.

  1996cited by this paper
• Dynamic fatty acylation of p21N‐ras.

  1987cited by this paper

• Advances in targeting protein S-palmitoylation in tumor immunity and therapy

  2025cites this paper
• ZDHHC5 as a central regulator in a palmitoylation-associated prognostic model for lung adenocarcinoma: insights from pan-cancer and experimental analyses

  2025cites this paper
• De novo transcriptome assembly and gene expression analysis of Cnidium officinale under high-temperature conditions

  2025cites this paper
• Gene regulation by non-Coding RNAs in infertility: a mechanistic review

  2025cites this paper
• Palmitoylation in cancer: decoding its roles in signal transduction, tumor immunity, and emerging therapeutic opportunities

  2025cites this paper
• Recent advances in S-palmitoylation and its emerging roles in human diseases

  2025cites this paper
• Palmitoylation: an emerging therapeutic target bridging physiology and disease

  2025cites this paper
• Palmitic acid and palmitoylation in cancer: Understanding, insights, and challenges

  2025cites this paper
• The Role of MicroRNAs, CircRNAs, and LncRNAs in Chronic Lymphocytic Leukemia.

  2025cites this paper
• Deacylases—structure, function, and relationship to diseases

  2024cites this paper
• Circular RNAs as a novel class of potential therapeutic and diagnostic biomarkers in reproductive biology/diseases

  2024cites this paper
• The role of CD95 in modulating CAR T-cell therapy: Challenges and therapeutic opportunities in oncology.

  2024cites this paper
• Dysregulated MicroRNAs in Chronic Lymphocytic Leukemia

  2024cites this paper
• Elucidating the pan-oncologic landscape of S100A9: prognostic and therapeutic corollaries from an integrative bioinformatics and Mendelian randomization analysis

  2024cites this paper
• Protein lipidation in cancer: mechanisms, dysregulation and emerging drug targets

  2024cites this paper
• Depalmitoylation and Cell Physiology: APT1 as a Mediator of Metabolic Signals.

  2024cites this paper
• Identification and prognostic biomarkers among ZDHHC4/12/18/24, and APT2 in lung adenocarcinoma

  2024cites this paper
• EBV and 1q Gains Affect Gene and miRNA Expression in Burkitt Lymphoma

  2023cites this paper
• Advances of Protein Palmitoylation in Tumor Cell Deaths

  2023cites this paper
• Global miRNA profiling reveals key molecules that contribute to different chronic lymphocytic leukemia incidences in Asian and Western populations

  2023cites this paper
• Protein palmitoylation in cancer: molecular functions and therapeutic potential

  2022cites this paper
• Deregulation and epigenetic modification of BCL2-family genes cause resistance to venetoclax in hematologic malignancies

  2022cites this paper
• The Cdc42 effector and non-receptor tyrosine kinase, ACK defines a distinct STAT5 transcription signature in a chronic myeloid leukaemia cell model

  2022cites this paper
• N-1,2,3-Triazole-isatin derivatives: anti-proliferation effects and target identification in solid tumour cell lines.

  2022cites this paper
• Emerging roles of protein palmitoylation and its modifying enzymes in cancer cell signal transduction and cancer therapy

  2022cites this paper
• A Pan-Cancer Analysis of the Oncogenic Role of Cell Division Cycle-Associated Protein 4 (CDCA4) in Human Tumors

  2022cites this paper
• Endothelial-Derived APT1-Mediated Macrophage-Endothelial Cell Interactions Participate in the Development of Atherosclerosis by Regulating the Ras/MAPK Signaling Pathway

  2022cites this paper
• An Analysis of BMP1 Associated with m6A Modification and Immune Infiltration in Pancancer

  2022cites this paper
• FAIM2 is a potential pan-cancer biomarker for prognosis and immune infiltration

  2022cites this paper
• An Integrative Pan-Cancer Analysis Revealing ETS1 as an Oncogenic Immune Protein in Tumor Microenvironment

  2021cites this paper
• MARCKS affects cell motility and response to BTK inhibitors in CLL.

  2021cites this paper
• Recent research progress on circular RNAs: Biogenesis, properties, functions, and therapeutic potential

  2021cites this paper
• Inhibition of the miR-155 and protein prenylation feedback loop alleviated acute graft-versus-host disease through regulating the balance between T helper 17 and Treg cells.

  2021cites this paper
• An Integrative Pan-Cancer Analysis Revealing LCN2 as an Oncogenic Immune Protein in Tumor Microenvironment

  2020cites this paper
• Protein Palmitoylation in Leukocyte Signaling and Function

  2020cites this paper
• Role of microRNAs in chronic lymphocytic leukemia pathogenesis.

  2019cites this paper
• DHHC5 REGULATES BETA-ADRENERGIC SIGNALING IN THE HEART THROUGH PALMITOYLATION OF G ALPHA PROTEINS

  2019cites this paper
• Protein Palmitoylation in Cancer

  2019cites this paper
• The molecular era of protein S-acylation: spotlight on structure, mechanisms, and dynamics

  2018cites this paper
• Protein depalmitoylases

  2018cites this paper
• State of the art in microRNA as diagnostic and therapeutic biomarkers in chronic lymphocytic leukemia

  2018cites this paper
• Circular RNA hsa_circ_0052112 promotes cell migration and invasion by acting as sponge for miR-125a-5p in breast cancer.

  2018cites this paper
• MicroRNA-322 Cluster Promotes Tau Phosphorylation via Targeting Brain-Derived Neurotrophic Factor

  2018cites this paper
• Targeting the Ras palmitoylation/depalmitoylation cycle in cancer.

  2017cites this paper
• Circular RNA: a new star in neurological diseases

  2017cites this paper
• Detection of S-Acylated CD95 by Acyl-Biotin Exchange.

  2017cites this paper
• CircDOCK1 suppresses cell apoptosis via inhibition of miR-196a-5p by targeting BIRC3 in OSCC

  2017cites this paper
• Dynamic Protein Acylation: New Substrates, Mechanisms, and Drug Targets.

  2017cites this paper
• Protein Lipidation As a Regulator of Apoptotic Calcium Release: Relevance to Cancer

  2017cites this paper
• MiR-138: A promising therapeutic target for cancer

  2017cites this paper
• Identification of microRNAs implicated in the late differentiation stages of normal B cells suggests a central role for miRNA targets ZEB1 and TP53

  2017cites this paper
• Circular RNA participates in the carcinogenesis and the malignant behavior of cancer

  2017cites this paper
• Chimeric antigen receptor T cells targeting Fc μ receptor selectively eliminate CLL cells while sparing healthy B cells.

  2016cites this paper
• Caractérisation des lymphocytes B régulateurs dans la leucémie lymphoïde chronique

  2016cites this paper
• Concepts of Chronic Lymphocytic Leukemia Pathogenesis: DNA Damage Response and Tumor Microenvironment

  2016cites this paper
• Palmitoylation in Alzheimer's disease and other neurodegenerative diseases.

  2016cites this paper
• Palmitoylation: a protein S-acylation with implications for breast cancer

  2016cites this paper
• Circular RNAs are miRNA sponges and can be used as a new class of biomarker.

  2016cites this paper
• Protein S-palmitoylation and cancer.

  2015cites this paper